Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.